Drug–drug interactions with pioglitazone, losartan, and midazolam and anti-tumor efficacy and safety study of TAS-115 in patients with solid tumors

Cancer Chemotherapy and Pharmacology · Published 2026-01-22 · DOI 10.1007/s00280-025-04855-9

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1007/s00280-025-04855-9

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• PPARγ suppresses the tumorigenesis of retroperitoneal liposarcoma via inactivation of the PI3K/AKT signaling pathway · Journal of Translational Medicine · 2026 · Cites or is cited by this article
• Deciphering autophagy-metabolism interactions in cancer drug resistance: a comprehensive review · Cancer Chemotherapy and Pharmacology · 2026 · Same journal
• Pharmacokinetic and pharmacogenomic profile of capecitabine and oxaliplatin in a patient with gastric cancer undergoing hemodialysis: a case report · Cancer Chemotherapy and Pharmacology · 2026 · Same journal
• Temozolomide resistance in glioma: aligning target discovery with clinically achievable CNS exposures and translational delivery strategies · Cancer Chemotherapy and Pharmacology · 2026 · Same journal
• Physiologically based pharmacokinetic modeling of granisetron for optimizing antiemetic therapy in patients with cancer: multi-route pharmacokinetic characterization and target-site exposure prediction · Cancer Chemotherapy and Pharmacology · 2026 · Same journal
• Transfer of trastuzumab and pertuzumab into human breast milk: a case report · Cancer Chemotherapy and Pharmacology · 2026 · Same journal
• Synergistic anti-tumor activity of andrographolide and gemcitabine in intrahepatic cholangiocarcinoma through inhibition of RRM2 and the JAK/STAT3 pathway · Cancer Chemotherapy and Pharmacology · 2026 · Same journal
• Zolbetuximab-induced gastric mucosal injury and hypoalbuminemia: a mechanism-informed clinical analysis · Cancer Chemotherapy and Pharmacology · 2026 · Same journal
• Pharmacologic de-escalation of dexamethasone during weekly paclitaxel: a randomized phase III trial evaluating safety, endocrine effects, and quality of life · Cancer Chemotherapy and Pharmacology · 2026 · Same journal
• Antibody–drug conjugates in colorectal cancer: molecular design, preclinical advances, and translational challenges · Cancer Chemotherapy and Pharmacology · 2026 · Same journal